Exec: Device tax counters principles of economic growth, job creation

11/21/2011 | Plain Dealer (Cleveland), The

The 2.3% medical device excise tax could lead to job cuts in the medtech industry by lowering the demand for costly devices and driving U.S. firms to move their operations overseas, writes BioOhio President and CEO Tony Dennis, citing an AdvaMed study. The tax, set to begin in 2013, "is counter to principles of economic growth and job creation" and "may stifle the kind of innovation that is essential to patients and the overall health care system," Dennis notes.

View Full Article in:

Plain Dealer (Cleveland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN